Thyrocare Technologies

Five asset managing companies including HDFC AMC, ICICI Pru MF, Eastspring Investments pick 7.9% stake in Thyrocare for Rs 527 crore

Promoter Docon Technologies has offloaded 53.3 lakh shares (10.06 percent of paid-up equity) in Thyrocare Technologies at Rs 1,252.03 per share for Rs 667.7 crore.

Buy Thyrocare Technologies; target of Rs 1560: ICICI Securities

ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 1560 in its research report dated October 15, 2025.

Stocks to Watch Today: Tech Mahindra, Persistent Systems, Thyrocare, Keystone Realtors, Mishra Dhatu, GR Infra, Saatvik Green Energy in focus on 15 October

Stocks to watch, 15 October: Stocks like Tech Mahindra, Persistent Systems, ICICI Lombard General Insurance Company, Cyient DLM, Thyrocare Technologies, Kolte-Patil Developers, Sula Vineyards, Ashiana Housing, Keystone Realtors, Saatvik Green Energy, Mishra Dhatu Nigam, G R Infraprojects, and Hyundai Motor India will be in focus on October 15.

Thyrocare net profit jumps 80% to Rs 48 crore in Q2, firm announces 2:1 bonus issue

Thyrocare Technologies share price: The company also announced an interim dividend of Rs 7 per share for the financial year 2026.

Trade Spotlight: How should you trade Hubtown, Thyrocare Tech, EID Parry, JSW Infrastructure, Rallis India, Piramal Enterprises and others on July 14?

Consolidation is expected to continue in the upcoming sessions until the frontline indices trade above their short-term moving averages. Below are some short-term trading ideas to consider.

InCred adds Thyrocare to conviction list, exits Marico, Pidilite, SBI Cards

InCred Equities added Thyrocare Technologies to its conviction list while exiting Pidilite, Marico, and SBI Cards, citing shifting fundamentals and earnings outlook

Buy Thyrocare Technologies; target of Rs 1000: ICICI Securities

ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 1000 in its research report dated April 24, 2025.

Thyrocare shares skyrocket 20% after profit, revenue see double-digit growth in Q4

Thyrocare Tech reported a 21.9 percent year-on-year increase in net profit, which stood at Rs 21.7 crore in Q4

Stocks to Watch Today: Tata Consumer Products, BPCL, Adani Green Energy, Panacea Biotec, Thyrocare, Bajaj Housing, LTIMindtree in focus on 24 April

Stocks to watch, 24 Apr: Stocks like Syngene International, Wendt India, Supreme Petrochem, 360 ONE WAM, Can Fin Homes, Rallis India, Tata Teleservices (Maharashtra), Tamilnad Mercantile Bank, Filatex India, Biocon, Niva Bupa Health Insurance Company, Spandana Sphoorty Financial, and Bajaj Finance will be in focus on April 24.

Thyrocare shares jump 6% after firm's Q3 net profit rises 24% to Rs 19 crore

Thyrocare reported 23% YoY rise in revenue in December quarter

Stock Radar: Wipro, Wonderla Holidays, EPACK Durable, RVNL, Reliance Power, Kaynes Technology in focus on Wednesday

Stocks like Oil and Natural Gas Corporation, Indian Energy Exchange, Nitiraj Engineers, Kore Digital, Hero MotoCorp, PTC India, HG Infra Engineering, Thyrocare Technologies, Max Healthcare Institute, and Deepak Nitrite will also be in focus on December 4.

Stock Radar: HUL, Escorts Kubota, NLC India, Nuvoco Vistas, AU SFB, VIP Industries, Thyrocare, Dr Lal PathLabs in focus on Thursday

Stocks like Sona BLW Precision Forgings, Birlasoft, Birla Corporation, Fedbank Financial Services, Karnataka Bank, MAS Financial Services, Navin Fluorine International, Schaeffler India, and Piramal Pharma will also be in focus on October 24.

Trade Spotlight: How should you trade HDFC AMC, Finolex Industries, Orient Cement, CESC, ITD Cementation and others on Thursday?

The consolidation in the market is expected to continue, with a focus on stock-specific action amid the earnings season. Below are some trading ideas for the near term.

Buy Thyrocare Technologies; target of Rs 825: ICICI Securities

ICICI Securities is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 825 in its research report dated July 24, 2024.